Introduction of indian originated world's Largest Generic medicinal manufacturer

1. Group no.3
1. Anmol Misal
2. Nency Makadia
3. Utkarsh Mali
4. Melvin Mathai
5. Bela Kunt
6. Aasawari
Naravnekar
7. Omkar patange
8. Tejas Pingle
9. Arjun Rastogi

2. SUN
Pharmaceutical industry
Leadership through focused research

3. LUPIN
Pharmaceutical industry
Being Lupin, enriching lives everyday

4. History
1983- Sun Pharmaceuticals was established in Vapi, Gujarat with five products.
1994- Sun Pharma was listed on the stock exchange.
1989- Exports to neighbouring countries began.
2000- Sun pharma ranked 4th largest pharmaceutical industry in world.
Today it is the largest chronic prescription company in india.
Its company head quarters is in Mumbai .
The founding family continues to hold a majority stake in the company

5. About LUPIN
The Indian originated fastest growing generic pharmaceutical industry.
The 3rd largest pharmaceutical company in India.
The 7th largest generic pharmaceutical company globally.
One of the largest manufacturer of TB drugs.
The company manufactures a products in therapy areas such as
cardiovascular, anti-asthma, anti-diabetic, CNS, gynaecology.

6. History
1968: Lupin founded by Mr. Desh Bandhu Gupta
1972: Lupin Laboratories Pvt. Ltd was incorporated
1980: Lupin started formulation plant and R&D centre at Aurangabad
2001: State of the art R&D centre at Pune was started

7. SIGNIFICANT MILESTONES
 1983: Sun Pharma established with five psychaitry products and a two person
marketing team
 1983: Sun pharma sets up compact manufacturing units for tablets and capsules at
Vapi, Gujarat
 1988: Sun pharma launches monotrate angizem first cardiology products that are
sold till today
 1989: Sun pharma introduces gastroenterology products in india
 1991: Sun pharma establishes first research centre to create a base for strong
product and process development
 1996: Sun Pharma expands sales network across 24 countries

8. SIGNIFICANT MILESTONES
 1968: Lupin commences business
 1972: Lupin laboratories private limited is incorporated
 1980: commissions first formulation plant and an R&D plant at aurangabad
 1988: Lupin human welfare and research foundation in founded by DR. Desh
Bandhu Gupta
 1993: Lupin laboratories and Lupin Chemicals raised money through IPO
 2004: Commences its US brands business with the launch of suprax
 2012: Enters the nifty 50 index

9. Collaboration & Acquisition
Acquisition:
 1996: Sun purchased drug manufacturing plants at Ahemadnagar from Knoll pharma
 1998: Purchased respiratory brand from natco pharma
 1999: acquired milmet labs and Gujarat lyka organic
 2000: Pradeep Drug Company
 2012: DUSA Pharmaceuticals a dermatology device company, URL Pharma a generic
pharma company
 2014: Sun pharma acquired 100% of Ranbaxy Lab Ltd.

10. Collaboration:
 Sun pharma and the technion have collaborated and
developed a new class of oncology drugs
 Sun pharma and ICGEB have announced to develop a new
dengue vaccine for India
 Sun pharma announced research collaboration with
weizmann institute of science Israel and health research
institute of Santiago, spain for brain therapy

11. Collaboration & Acquisition
Collaboration:
American Academy of ophthalmology & Lupin
Boehringer Ingelheim India & Lupin
Acquisition:
2016: Lupin completed acquisition of GAVIS Pharma
2017: Lupin acquires Symbiomix therapeutics LLC

12. VISION, MISSION AND VALUES
VISION : Reaching People and Touching Lives Globally as a Leading Provider of Valued Medicines
VALUES :
Quality Get it right the first time
• Reliability Maintain efficiency & discipline in all processes & systems and fulfil the promises made to
stakeholders.
• Consistency Endeavour to bring new products to the market & consistently deliver value to
stakeholders.
• Trust Be transparent in dealings.
• Innovation Implement new ideas & technologies to meet unmet needs and think ahead of times.
MISSION : sun pharma believes in good health and happiness they also believe in utilising modern science

13. Vision & Mission
Vision:
Lupin Pharmaceuticals, Inc. is committed to bringing innovative products for the
healthcare professional to improve the health and well being of individuals.
Mission:
Lupin's mission is to become a transnational pharmaceutical company through the
development and introduction of a wide portfolio of branded and generic products in
key markets.

14. SUN Goals
Growing healthcare budget for drug therapy.
Population Aging.
Improved Compliance rates among patients.
Need for Cost Containment.

15. Lupin Goal
Focus on branded generic business in the US.
Growing Japanese generic market.
Company also keen on Inorganic Growth.

16. Board of Directors
•
Managing Director
Mr. Dilip Sanghavi
Chairman
Israel Makov
Executive Director
Sailesh T Desai
Executive Director
Sudhir V. Valla

17. Board of Directors
Founder & Chairman:
Dr. Desh Bandhu Gupta
Vice chairman:
Dr. Kamal K. Sharma
CEO & Director:
Mrs. Vinita Gupta
Executive Director:
Mrs. M.D. Gupta
Managing Director:
Mr. Nilesh Gupta